Symbols / INCR Stock $0.90 -0.97% InterCure Ltd.

Healthcare • Drug Manufacturers - Specialty & Generic • Israel • NGM
INCR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Alexander Rabinovich
Exch · Country NGM · Israel
Market Cap 49.15M
Enterprise Value —
Income —
Sales —
FCF (ttm) -18.40M
Book/sh 7.59
Cash/sh —
Employees 320
Insider 10d —
IPO Jan 28, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.61
PEG —
P/S —
P/B 0.12
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio 1.08
Current Ratio 1.85
Debt/Eq 41.49
LT Debt/Eq —
EPS (ttm) -0.52
EPS next Y -1.48
EPS Growth —
Revenue Growth 3.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2023-08-31
Earnings (prior) 2023-08-31
ROA -7.74%
ROE -16.68%
ROIC —
Gross Margin 16.71%
Oper. Margin 0.00%
Profit Margin -29.17%
Shs Outstand 54.68M
Shs Float 38.87M
Insider Own 26.05%
Instit Own 1.33%
Short Float 0.02%
Short Ratio 0.34
Short Interest 7.62K
52W High 1.77
vs 52W High -49.21%
52W Low 0.68
vs 52W Low 32.19%
Beta 0.33
Impl. Vol. 3.00%
Rel Volume 0.58
Avg Volume 42.20K
Volume 24.39K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.91
Price $0.90
Change -0.97%
About

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.90
Latest analyst target
3. DCF / Fair value
$-6.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.90
Low
—
High
—
Mean
—
News
RSS: Latest INCR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2022-03-23 Fegel (Yael) 10% Security Holder of Issuer — 1,823 $22.70 $41,382
2022-03-22 Fegel (Yael) 10% Security Holder of Issuer — 100,000 $22.85 $2,285,000
2022-03-21 Fegel (Yael) 10% Security Holder of Issuer — 48,362 $22.50 $1,088,145
2022-03-16 Fegel (Yael) 10% Security Holder of Issuer — 1,224 $21.10 $25,826
2022-03-15 Fegel (Yael) 10% Security Holder of Issuer — 3,000 $21.08 $63,239
2022-03-15 Fegel (Yael) 10% Security Holder of Issuer — 6,000 $21.24 $127,439
2022-03-15 Fegel (Yael) 10% Security Holder of Issuer — 10,000 $21.06 $210,600
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
238.84
-32.82%
355.55
-8.52%
388.68
+76.93%
219.68
Operating Revenue
238.84
-32.82%
355.55
-8.52%
388.68
+76.93%
219.68
Cost Of Revenue
208.61
-16.71%
250.46
+7.22%
233.60
+81.73%
128.55
Reconciled Cost Of Revenue
201.91
-17.64%
245.16
+8.42%
226.13
+82.24%
124.08
Gross Profit
30.23
-71.23%
105.09
-32.23%
155.08
+70.18%
91.13
Operating Expense
75.29
+11.54%
67.50
-40.73%
113.88
+95.99%
58.11
Research And Development
0.41
+6.70%
0.39
-38.61%
0.63
-48.83%
1.24
Selling General And Administration
84.63
-1.86%
86.24
-11.39%
97.32
+82.03%
53.46
Selling And Marketing Expense
21.71
-1.03%
21.94
+8.02%
20.31
+148.84%
8.16
General And Administrative Expense
62.92
-2.14%
64.30
-16.50%
77.01
+69.99%
45.30
Salaries And Wages
43.14
-3.46%
44.68
-21.49%
56.91
+85.11%
30.75
Other Gand A
12.35
+3.68%
11.91
-0.37%
11.95
+31.93%
9.06
Other Operating Expenses
-32.90
-9.37%
-30.08
—
—
Total Expenses
283.90
-10.71%
317.96
-8.50%
347.48
+86.17%
186.65
Operating Income
-45.06
-219.85%
37.59
-8.75%
41.20
+24.76%
33.02
Total Operating Income As Reported
-67.21
-61.69%
-41.57
-182.10%
50.63
+79.62%
28.18
EBITDA
-51.31
-114.67%
-23.90
-134.03%
70.23
+125.30%
31.17
Normalized EBITDA
-39.07
-181.56%
47.90
-8.78%
52.51
+39.73%
37.58
Reconciled Depreciation
15.37
+16.75%
13.17
+12.54%
11.70
+58.24%
7.39
EBIT
-66.68
-79.89%
-37.07
-163.33%
58.53
+146.15%
23.78
Total Unusual Items
-12.24
+82.95%
-71.80
-505.09%
17.72
+376.76%
-6.40
Total Unusual Items Excluding Goodwill
-12.24
+82.95%
-71.80
-505.09%
17.72
+376.76%
-6.40
Special Income Charges
0.00
+100.00%
-68.76
-750.37%
10.57
0.00
Impairment Of Capital Assets
0.00
-100.00%
67.69
0.00
0.00
Restructuring And Mergern Acquisition
0.00
-100.00%
1.07
+110.09%
-10.57
0.00
Net Income
-67.80
-9.42%
-61.96
-238.24%
44.82
+855.63%
4.69
Pretax Income
-87.32
-42.49%
-61.28
-239.79%
43.84
+134.02%
18.73
Net Non Operating Interest Income Expense
-20.09
-2.14%
-19.67
-39.41%
-14.11
-187.10%
-4.92
Interest Expense Non Operating
20.64
-14.76%
24.22
+64.88%
14.69
+191.16%
5.04
Net Interest Income
-20.09
-2.14%
-19.67
-39.41%
-14.11
-187.10%
-4.92
Interest Expense
20.64
-14.76%
24.22
+64.88%
14.69
+191.16%
5.04
Interest Income Non Operating
2.70
-49.77%
5.38
+536.85%
0.84
+549.23%
0.13
Interest Income
2.70
-49.77%
5.38
+536.85%
0.84
+549.23%
0.13
Other Income Expense
-22.18
+72.00%
-79.21
-572.79%
16.75
+278.70%
-9.38
Other Non Operating Income Expenses
-9.94
-34.14%
-7.41
-662.92%
-0.97
+67.32%
-2.97
Gain On Sale Of Security
-12.24
-302.50%
-3.04
-142.52%
7.15
+211.68%
-6.40
Tax Provision
-14.53
-746.35%
2.25
+2317.20%
0.09
-99.19%
11.44
Tax Rate For Calcs
0.00
-27.65%
0.00
+10743.94%
0.00
-99.08%
0.00
Tax Effect Of Unusual Items
-2.04
+87.67%
-16.51
-44022.38%
0.04
+102.55%
-1.47
Net Income Including Noncontrolling Interests
-72.79
-14.58%
-63.53
-245.22%
43.75
+499.88%
7.29
Net Income From Continuing Operation Net Minority Interest
-67.80
-9.42%
-61.96
-238.24%
44.82
+855.63%
4.69
Net Income From Continuing And Discontinued Operation
-67.80
-9.42%
-61.96
-238.24%
44.82
+855.63%
4.69
Net Income Continuous Operations
-72.79
-14.58%
-63.53
-245.22%
43.75
+499.88%
7.29
Minority Interests
5.00
+217.53%
1.57
+47.10%
1.07
+141.11%
-2.60
Normalized Income
-57.59
-762.86%
-6.67
-124.60%
27.13
+182.01%
9.62
Net Income Common Stockholders
-67.80
-9.42%
-61.96
-238.24%
44.82
+855.63%
4.69
Diluted EPS
—
-1.36
-237.37%
0.99
+890.00%
0.10
Basic EPS
—
-1.36
-237.37%
0.99
+725.00%
0.12
Basic Average Shares
—
45.87
+1.14%
45.35
+17.82%
38.49
Diluted Average Shares
—
45.87
+1.14%
45.35
-3.34%
46.92
Diluted NI Availto Com Stockholders
-67.80
-9.42%
-61.96
-238.24%
44.82
+855.63%
4.69
Depreciation Amortization Depletion Income Statement
8.67
+10.10%
7.87
+86.34%
4.22
+44.11%
2.93
Depreciation And Amortization In Income Statement
8.67
+10.10%
7.87
+86.34%
4.22
+44.11%
2.93
Depreciation Income Statement
8.67
+10.10%
7.87
+86.34%
4.22
+44.11%
2.93
Earnings From Equity Interest
—
—
—
0.00
Insurance And Claims
1.64
-6.23%
1.75
-18.54%
2.15
-19.32%
2.66
Provision For Doubtful Accounts
14.47
+369.05%
3.09
-73.64%
11.71
+2354.72%
0.48
Rent And Landing Fees
5.80
-2.72%
5.96
-0.65%
6.00
+111.39%
2.84
Rent Expense Supplemental
5.80
-2.72%
5.96
-0.65%
6.00
+111.39%
2.84
Total Other Finance Cost
2.15
+159.30%
0.83
+211.28%
0.27
—
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
762.57
-3.06%
786.61
-17.89%
958.01
+37.54%
696.54
Current Assets
391.80
-6.45%
418.80
-20.60%
527.49
+56.92%
336.16
Cash Cash Equivalents And Short Term Investments
78.65
-22.38%
101.33
-56.47%
232.79
+18.44%
196.55
Cash And Cash Equivalents
78.32
-22.56%
101.14
-56.52%
232.59
+18.54%
196.22
Cash Equivalents
60.55
+858.02%
6.32
-84.29%
40.24
+1239.93%
3.00
Cash Financial
17.77
-81.26%
94.82
-50.71%
192.35
-0.45%
193.21
Other Short Term Investments
0.33
+78.07%
0.19
-8.78%
0.20
-37.88%
0.33
Receivables
180.50
+5.69%
170.78
+31.42%
129.95
+246.24%
37.53
Accounts Receivable
51.85
-14.18%
60.41
+63.63%
36.92
+112.09%
17.41
Gross Accounts Receivable
59.60
-9.15%
65.60
+70.09%
38.57
+110.51%
18.32
Allowance For Doubtful Accounts Receivable
-7.75
-49.47%
-5.18
-214.81%
-1.65
-80.39%
-0.91
Other Receivables
87.18
+31.26%
66.42
+427.47%
12.59
-18.47%
15.45
Loans Receivable
40.86
+0.80%
40.53
-37.02%
64.35
+1275.04%
4.68
Inventory
125.33
+17.91%
106.29
-27.45%
146.50
+115.82%
67.88
Work In Process
57.60
+27.99%
45.00
-49.99%
89.99
+290.31%
23.06
Finished Goods
62.71
+3.70%
60.47
+20.60%
50.14
+27.73%
39.26
Prepaid Assets
6.01
-80.46%
30.75
+607.85%
4.34
-66.89%
13.12
Restricted Cash
1.32
-86.38%
9.66
-30.54%
13.91
-34.04%
21.08
Total Non Current Assets
370.77
+0.81%
367.81
-10.40%
410.51
+13.91%
360.38
Net PPE
105.24
+7.97%
97.47
-5.49%
103.13
+19.22%
86.51
Gross PPE
159.71
+16.03%
137.64
+8.96%
126.32
+28.90%
98.00
Accumulated Depreciation
-54.46
-35.58%
-40.17
-73.24%
-23.19
-101.84%
-11.49
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
91.29
+16.74%
78.20
+11.50%
70.13
+19.28%
58.80
Machinery Furniture Equipment
24.83
+6.07%
23.41
+4.42%
22.42
+85.52%
12.08
Other Properties
43.59
+20.96%
36.03
+6.71%
33.77
+24.54%
27.11
Goodwill And Other Intangible Assets
224.59
+1.59%
221.08
-22.20%
284.18
+5.92%
268.29
Goodwill
224.59
+1.59%
221.08
-22.20%
284.18
+5.92%
268.29
Investments And Advances
2.15
+11.71%
1.92
-25.07%
2.56
+0.00%
2.56
Long Term Equity Investment
—
—
40.00
0.00
Non Current Accounts Receivable
0.42
-89.95%
4.21
—
—
Non Current Deferred Assets
38.37
+55.44%
24.68
+19.61%
20.64
+583.28%
3.02
Non Current Deferred Taxes Assets
38.37
+55.44%
24.68
+19.61%
20.64
+583.28%
3.02
Total Liabilities Net Minority Interest
364.90
+10.73%
329.55
-24.51%
436.53
+92.19%
227.13
Current Liabilities
226.75
+0.39%
225.87
-27.77%
312.72
+61.54%
193.59
Payables And Accrued Expenses
114.56
-8.26%
124.87
-20.92%
157.91
+84.77%
85.46
Payables
100.21
-10.82%
112.37
-23.72%
147.32
+98.38%
74.26
Accounts Payable
77.54
-1.15%
78.44
-37.78%
126.07
+95.53%
64.47
Other Payable
22.67
-33.18%
33.93
+59.66%
21.25
+117.13%
9.79
Current Accrued Expenses
14.35
+14.79%
12.50
+18.04%
10.59
-5.47%
11.20
Employee Benefits
0.97
+15.70%
0.84
-17.95%
1.02
+357.59%
0.22
Current Debt And Capital Lease Obligation
74.22
-20.05%
92.83
-29.87%
132.37
+75.13%
75.59
Current Debt
69.44
-21.27%
88.19
-31.11%
128.03
+77.12%
72.28
Other Current Borrowings
69.44
-21.27%
88.19
-31.11%
128.03
+77.12%
72.28
Current Capital Lease Obligation
4.79
+3.21%
4.64
+6.69%
4.35
+31.51%
3.31
Current Deferred Liabilities
0.00
-100.00%
4.08
-66.57%
12.21
-27.14%
16.75
Current Deferred Revenue
—
0.00
-100.00%
8.06
+177.84%
2.90
Other Current Liabilities
37.97
+830.08%
4.08
-60.10%
10.23
-35.17%
15.78
Total Non Current Liabilities Net Minority Interest
138.15
+33.24%
103.68
-16.26%
123.81
+269.06%
33.55
Long Term Debt And Capital Lease Obligation
137.18
+33.39%
102.84
-16.24%
122.79
+268.46%
33.32
Long Term Debt
113.98
+38.66%
82.20
-17.54%
99.68
+733.97%
11.95
Long Term Capital Lease Obligation
23.20
+12.40%
20.64
-10.65%
23.10
+8.10%
21.37
Stockholders Equity
396.97
-12.78%
455.11
-9.21%
501.31
+11.89%
448.03
Common Stock Equity
396.97
-12.78%
455.11
-9.21%
501.31
+11.89%
448.03
Capital Stock
658.60
+2.40%
643.16
+1.76%
632.02
+1.36%
623.57
Common Stock
658.60
+2.40%
643.16
+1.76%
632.02
+1.36%
623.57
Share Issued
45.77
+0.42%
45.57
0.00%
45.57
+0.97%
45.13
Ordinary Shares Number
47.16
+3.49%
45.57
0.00%
45.57
+0.97%
45.13
Retained Earnings
-277.58
-36.07%
-204.00
-44.01%
-141.65
+24.04%
-186.47
Gains Losses Not Affecting Retained Earnings
15.95
+0.00%
15.95
+567.88%
2.39
+0.00%
2.39
Minority Interest
0.70
-64.00%
1.95
-90.33%
20.17
-5.67%
21.38
Other Equity Adjustments
15.95
+0.00%
15.95
+567.88%
2.39
+0.00%
2.39
Total Equity Gross Minority Interest
397.67
-12.99%
457.06
-12.35%
521.48
+11.09%
469.41
Total Capitalization
510.95
-4.91%
537.31
-10.60%
600.99
+30.66%
459.98
Working Capital
165.05
-14.45%
192.94
-10.17%
214.77
+50.64%
142.57
Invested Capital
580.38
-7.21%
625.51
-14.20%
729.01
+36.97%
532.26
Total Debt
211.40
+8.04%
195.68
-23.31%
255.16
+134.28%
108.91
Net Debt
105.10
+51.75%
69.26
—
—
Capital Lease Obligations
27.99
+10.72%
25.28
-7.90%
27.45
+11.24%
24.68
Net Tangible Assets
172.38
-26.35%
234.03
+7.79%
217.12
+20.80%
179.74
Tangible Book Value
172.38
-26.35%
234.03
+7.79%
217.12
+20.80%
179.74
Duefrom Related Parties Current
0.61
-82.03%
3.42
-78.77%
16.09
0.00
Financial Assets Designatedas Fair Value Through Profitor Loss Total
2.15
+11.71%
1.92
-25.07%
2.56
+0.00%
2.56
Investmentin Financial Assets
2.15
+11.71%
1.92
-25.07%
2.56
+0.00%
2.56
Investmentsin Associatesat Cost
—
—
40.00
0.00
Non Current Note Receivables
0.00
-100.00%
18.45
—
—
Other Equity Interest
—
—
8.54
+0.00%
8.54
Other Inventories
5.02
+511.07%
0.82
-87.09%
6.37
+14.36%
5.57
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-66.93
-24.79%
-53.63
-204.61%
51.27
+70.12%
30.14
Cash Flow From Continuing Operating Activities
-66.93
-24.79%
-53.63
-204.61%
51.27
+70.12%
30.14
Net Income From Continuing Operations
-72.79
-14.58%
-63.53
-245.22%
43.75
+499.88%
7.29
Depreciation Amortization Depletion
15.37
+16.75%
13.17
+12.54%
11.70
+58.24%
7.39
Depreciation
15.37
+16.75%
13.17
+12.54%
11.70
+58.24%
7.39
Depreciation And Amortization
15.37
+16.75%
13.17
+12.54%
11.70
+58.24%
7.39
Other Non Cash Items
26.20
+18.53%
22.10
+894.43%
-2.78
-129.44%
9.45
Pension And Employee Benefit Expense
0.13
+171.74%
-0.18
-144.02%
0.42
+233.12%
-0.31
Stock Based Compensation
2.28
-12.00%
2.59
-70.90%
8.91
+38.05%
6.45
Asset Impairment Charge
0.00
-100.00%
63.10
0.00
0.00
Deferred Tax
-14.53
-746.35%
2.25
+2317.20%
0.09
-99.19%
11.44
Deferred Income Tax
-14.53
-746.35%
2.25
+2317.20%
0.09
-99.19%
11.44
Operating Gains Losses
-1.00
-120.80%
4.82
+1052.39%
0.42
+233.12%
-0.31
Unrealized Gain Loss On Investment Securities
-0.37
-156.13%
0.66
+284.30%
0.17
-90.79%
1.87
Gain Loss On Sale Of PPE
0.39
-4.37%
0.41
0.00
0.00
Change In Working Capital
-9.19
+89.92%
-91.17
-2920.97%
-3.02
-82.58%
-1.65
Change In Receivables
13.26
+115.00%
-88.41
-627.85%
16.75
+313.25%
4.05
Changes In Account Receivables
8.43
+135.87%
-23.49
-28.47%
-18.29
-317.92%
8.39
Change In Inventory
-17.44
-143.37%
40.21
+152.91%
-75.99
-324.80%
-17.89
Change In Payables And Accrued Expense
-5.02
+88.32%
-42.97
-176.43%
56.22
+361.51%
12.18
Change In Payable
-5.02
+88.32%
-42.97
-176.43%
56.22
+361.51%
12.18
Change In Account Payable
-8.90
+81.31%
-47.63
-183.51%
57.03
+1946.39%
2.79
Change In Other Current Assets
—
—
—
-2.41
Investing Cash Flow
17.69
+270.61%
4.77
+103.35%
-142.50
-118.52%
-65.21
Cash Flow From Continuing Investing Activities
17.69
+270.61%
4.77
+103.35%
-142.50
-118.52%
-65.21
Net PPE Purchase And Sale
-4.38
-68.70%
-2.59
+86.86%
-19.74
-40.73%
-14.03
Purchase Of PPE
-4.38
-67.09%
-2.62
+86.73%
-19.74
-40.73%
-14.03
Sale Of PPE
0.00
-100.00%
0.03
0.00
0.00
Capital Expenditure
-4.38
-67.09%
-2.62
+86.73%
-19.74
-40.73%
-14.03
Net Investment Purchase And Sale
—
—
0.00
+100.00%
-1.25
Purchase Of Investment
—
—
0.00
+100.00%
-1.25
Net Business Purchase And Sale
0.41
+109.64%
-4.20
+71.00%
-14.48
+35.89%
-22.59
Purchase Of Business
-0.70
+83.26%
-4.20
+73.82%
-16.04
+28.99%
-22.59
Gain Loss On Sale Of Business
-1.53
-133.30%
4.59
0.00
—
Net Other Investing Changes
21.66
+102.01%
10.72
+109.90%
-108.27
-278.73%
-28.59
Financing Cash Flow
26.45
+131.92%
-82.89
-168.82%
120.45
-39.15%
197.94
Cash Flow From Continuing Financing Activities
26.45
+131.92%
-82.89
-168.82%
120.45
-39.15%
197.94
Net Issuance Payments Of Debt
7.74
+112.49%
-61.98
-145.00%
137.73
+109.23%
65.83
Issuance Of Debt
188.44
+200.42%
62.73
-76.19%
263.47
+249.17%
75.46
Repayment Of Debt
-180.70
-44.90%
-124.71
+0.82%
-125.74
-1205.75%
-9.63
Long Term Debt Issuance
188.44
+200.42%
62.73
-76.19%
263.47
+249.17%
75.46
Long Term Debt Payments
-180.70
-44.90%
-124.71
+0.82%
-125.74
-1205.75%
-9.63
Net Long Term Debt Issuance
7.74
+112.49%
-61.98
-145.00%
137.73
+109.23%
65.83
Net Common Stock Issuance
34.00
0.00
0.00
-100.00%
128.73
Cash Dividends Paid
0.00
0.00
0.00
0.00
Proceeds From Stock Option Exercised
—
0.00
0.00
-100.00%
8.50
Net Other Financing Charges
-0.10
—
—
—
Changes In Cash
-22.78
+82.71%
-131.75
-550.94%
29.22
-82.06%
162.87
Effect Of Exchange Rate Changes
-0.04
-113.13%
0.30
-95.85%
7.16
+257.76%
-4.54
Beginning Cash Position
101.14
-56.52%
232.59
+18.54%
196.22
+417.89%
37.89
End Cash Position
78.32
-22.56%
101.14
-56.52%
232.59
+18.54%
196.22
Free Cash Flow
-71.30
-26.76%
-56.25
-278.43%
31.52
+95.72%
16.11
Common Stock Issuance
34.00
0.00
0.00
-100.00%
128.73
Earnings Losses From Equity Investments
—
—
—
0.00
Interest Paid CFF
-15.19
+27.34%
-20.91
-20.96%
-17.28
-237.84%
-5.12
Interest Paid CFO
—
—
—
-5.12
Interest Received CFI
0.00
-100.00%
0.84
0.00
—
Interest Received CFO
—
—
—
-5.12
Issuance Of Capital Stock
34.00
0.00
0.00
-100.00%
128.73
Sale Of Business
1.11
0.00
-100.00%
1.56
—
Taxes Refund Paid
-12.89
-69.32%
-7.61
+4.52%
-7.97
+32.43%
-11.80
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category